Rubella screening: Difference between revisions
No edit summary |
m (Changes made per Mahshid's request) |
||
| Line 16: | Line 16: | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Togaviruses]] | [[Category:Togaviruses]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Primary care]] | [[Category:Primary care]] | ||
Revision as of 18:40, 18 September 2017
|
Rubella Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Rubella screening On the Web |
|
American Roentgen Ray Society Images of Rubella screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Michael Maddaleni, B.S., Aravind Kuchkuntla, M.B.B.S[2]
Overview
There are no standard screening test recommended for rubella infection, however pregnant women with suspected rubella infection must be investigated to confirm the diagnosis to prevent fetal anomalies.[1]
Screening
There is no screening test for rubella, however, if there is a high clinical suspicion of rubella infection during pregnancy, serum IgG and IgM antibodies against rubella may be ordered. Also, if a pregnant woman proves to be not immune aganist rubella, vaccination with MMR should be deferred till after delivery due to the theoretical teratogenic effects of the rubella vaccine.[2][3][4]
References
- ↑ Gerace TM (1987). "Rubella screening and immunization: its history and future-an ongoing challenge". Can Fam Physician. 33: 111–5. PMC 2218305. PMID 21267342.
- ↑ U.S. Preventive Services Task Force https://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=congenital+rubella+syndrome. Accessed on Jan 17, 2017.
- ↑ Center for Disease Control and Prevention https://www.cdc.gov/vaccines/pubs/surv-manual/chpt14-rubella.html. Accessed on Jan 17, 2017.
- ↑ Snell LB, Smith C, Chaytor S, McRae K, Patel M, Griffiths P (2017). "Screening for potential susceptibility to rubella in an antenatal population: A multivariate analysis". J Med Virol. doi:10.1002/jmv.24818. PMID 28370103.